CEO of Shanghai Realbio Technology Co. LTD
Qiang LiuQiang graduated from Shandong University with a major in microbiology. With over 10 years of industrial experience in diagnostic reagents, he has held important positions such as sales directors in a number of well-known companies and is responsible for corporate marketing and integrated business development. Currently, Qiang is responsible for the construction of RBT's management and organization system.
Chief Operating Officer
Hongwei YanTen years of marketing experience in the pharmaceutical industry of foreign-funded pharmaceutical companies has a deep understanding and insight into the development and management of China's pharmaceutical and testing marketing industries. He has nearly ten years of senior management experience focusing on national marketing and company operations, including self-employment, company operations and management in the field of blood, infection, and tumor oncology. , Yuce Bio Marketing VP. During the period of self-employment, he was responsible for the company's internal management operations and marketing, and has extensive experience in company management and marketing operations.
General Manager of Marketing Center
Jing LiuPh.D. from Zhejiang University, 2010-2011 State-sponsored Australian Commonwealth Scientific and Industrial Research Organization (CSIRO) for visiting study. From 2014 to 2016, she was engaged in post-doctoral research at Zhejiang University, during which she received second-class funding from the Postdoctoral Science Foundation. With eight years of experience in human microbiome research, a number of research results have been published in mainstream SCI journals such as FEMS Microbiology Ecology, Current Microbiology, BMC Microbiology, etc.
General Manager of Business Operation Center
Qian XuQian began his study in United States after graduation from Zhejiang University in 2001, and received his Ph.D in biology at Virginia Tech. He worked as a postdoc at University of California, Santa Barbara and University of North Carolina at Chapel Hill from 2008 to 2013. During his study in America, he focused on molecular microbiology research and published more than 10 papers in top microbiology journals such as J Bacteriol, Mol Microbiol, and Infect Immun.
Chief Technology Officer